Braxton B. Wannamaker, M.D., is an internationally renowned epilepsy specialist with extensive clinical and research experience and a former president of the American Epilepsy Society.
Dr. Wannamaker’s research interests include sudden death, the clinical pharmacology of antiepileptic drugs and the epidemiology of epilepsy. He has participated in numerous clinical trials, his research has been published in various journals and he as served on the editorial board of Epilepsia. A former member of the Epilepsy Foundation of South Carolina board of directors, Dr. Wannamaker also served on the professional advisory board and as chairman of the continuing and professional education committee for the Epilepsy Foundation of America. As a past president and a member of the American Epilepsy Society since 1976, he has enjoyed working on various committees, including serving as chair of the continuing education and the research recognition and awards committees. He currently serves as chair of the Lennox fund and is active on several committees and task forces.
Earlier in his career, Dr. Wannamaker served in various positions on the MUSC faculty, including director of the EEG laboratory and director of the seizure unit. He went on to develop the epilepsy unit at Roper Hospital in Charleston. He also has pursued private practice in Charleston and Orangeburg.
After receiving his BS from Clemson University in 1962, Dr. Wannamaker received his M.D. from MUSC. He completed his internship, neurology residency and NIH research fellowship in neurochemistry at the University of Wisconsin Hospitals in Madison.